(Q34515780)

2 August 2017

1 reference

title

The metastasis gene osteopontin: a candidate target for cancer therapy (English)

1 reference

2 August 2017

G F Weber

1

1 reference

PubMed ID

11825687

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Biochimica et Biophysica Acta

2 August 2017

1 reference

2 August 2017

1552

1 reference

2 August 2017

2

1 reference

2 August 2017

61-85

1 reference

Stress response genes: the genes that make cancer metastasize

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Participation in normal immune responses of a metastasis-inducing splice variant of CD44

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Posttranslational modifications of bovine osteopontin: identification of twenty-eight phosphorylation and three O-glycosylation sites

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Identification of two phosphorylation motifs in bovine osteopontin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Phosphorylation of purified bovine bone sialoprotein and osteopontin by protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Identification of the Phosphorylated Sites of Metabolically32P-Labeled Osteopontin from Cultured Chicken Osteoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Overcoming obstacles to metastasis--defenses against host defenses: osteopontin (OPN) as a shield against attack by cytotoxic host cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Receptor-ligand interaction between CD44 and osteopontin (Eta-1)

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Osteopontin expression correlates with clinical outcome in patients with mycobacterial infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Altered wound healing in mice lacking a functional osteopontin gene (spp1).

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Differential expression of osteopontin, PC4, and CEC5, a novel mRNA species, during in vitro angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Immunohistochemical and molecular characterization of the differential response of the rat mesenteric microvasculature to angiotensin-II infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Angiotensin II induction of osteopontin expression and DNA replication in rat arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Osteopontin-induced modifications of cellular functions.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Upregulation of osteopontin expression by ischemia in rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Costimulation by extracellular matrix proteins determines the response to TCR ligation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Osteopontin, a substrate for transglutaminase and Factor XIII activity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Osteopontin: its transglutaminase-catalyzed posttranslational modifications and cross-linking to fibronectin.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Localization of transglutaminase-reactive glutamine residues in bovine osteopontin.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Tissue transglutaminase and factor XIII in cartilage and bone remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Sulphation of secreted phosphoprotein I (SPPI, osteopontin) is associated with mineralized tissue formation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Osteopontin: a protein with diverse functions.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Osteopontin is required for full expression of the transformed phenotype by the ras oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Integrin alpha V beta 3 expression by bone-residing breast cancer metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Immunohistochemical analysis of integrin alpha vbeta3 expression on tumor-associated vessels of human carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the alpha(v)beta(3) and alpha(5)beta(1) integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

A regulated interaction between alpha5beta1 integrin and osteopontin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Analysis of the alpha4beta1 integrin-osteopontin interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Hoxa-9 represses transforming growth factor-beta-induced osteopontin gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Stimulation of osteopontin mRNA expression in HL-60 cells is independent of differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Acidic fibroblast growth factor inhibits osteoblast differentiation in vitro: altered expression of collagenase, cell growth-related, and mineralization-associated genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Actions of bFGF on mitogenic activity and lineage expression in rat osteoprogenitor cells: effect of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Cox-2 and osteopontin in cocultured platelets and mesangial cells: role of glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Glucocorticoids increase osteopontin expression in cardiac myocytes and microvascular endothelial cells. Role in regulation of inducible nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Transcriptional targets shared by estrogen receptor- related receptors (ERRs) and estrogen receptor (ER) alpha, but not by ERbeta

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

p21ras and protein kinase C function in distinct and interdependent signaling pathways in C3H 10T1/2 fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Signal transduction of mechanical stimuli is dependent on microfilament integrity: identification of osteopontin as a mechanically induced gene in osteoblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Enhanced expression of osteopontin by high glucose in cultured rat aortic smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Antitumor efficacy of hypothemycin, a new Ras-signaling inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Ribozyme-mediated inactivation of mutant K-ras oncogene in a colon cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Stimulation of mouse osteopontin promoter by v-Src is mediated by a CCAAT box-binding factor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Antibodies to different peptides in osteopontin reveal complexities in the various secreted forms

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Differential regulation of the 55 and 44 kDa forms of secreted phosphoprotein 1 (SPP-1, osteopontin) in normal and transformed rat bone cells by osteotropic hormones, growth factors and a tumor promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Altered sialylation of osteopontin prevents its receptor-mediated binding on the surface of oncogenically transformed tsB77 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

The cDNA and derived amino acid sequence for human osteopontin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Anti-K-ras ribozyme induces growth inhibition and increased chemosensitivity in human colon cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Design and testing of ribozymes for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Adenovirus-mediated anti-K-ras ribozyme induces apoptosis and growth suppression of human pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Osteopontin (OPN) may facilitate metastasis by protecting cells from macrophage NO-mediated cytotoxicity: evidence from cell lines down-regulated for OPN expression by a targeted ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Expression of Antisense Osteopontin RNA in Metastatic Mouse Fibroblasts Is Associated with Reduced Malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Detection of mouse osteopontin by western blotting.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Rat osteoclasts adhere to a wide range of RGD (Arg-Gly-Asp) peptide-containing proteins, including the bone sialoproteins and fibronectin, via a beta 3 integrin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Synthesis, NMR spectra and function of peptides with alpha-methylserine attached to the RGD sequence of osteopontin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Direct thrombin inhibitors as adjuncts to thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

In vitro phosphorylation of mouse osteopontin expressed in E. coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Phosphorylation of Osteopontin by Golgi Kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Protein kinases of cultured osteoblasts: Selectivity for the extracellular matrix proteins of bone and their catalytic competence for osteopontin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Transglutaminase-catalyzed cross-linking of osteopontin is inhibited by osteocalcin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Primary amines inhibit recycling of α2M receptors in fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Increase in proliferative markers after inhibition of transglutaminase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Chimeric peptides of statherin and osteopontin that bind hydroxyapatite and mediate cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Constrained cell recognition peptides engineered into streptavidin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Regulation of CD44 isoform expression and CD44-mediated signaling in human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Oncogene-dependent expression of CD44 in Balb/c 3T3 derivatives: correlation with metastatic competence

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Prevention of tumor metastasis formation by anti-variant CD44.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Development of GnRH antagonists for prostate cancer: new approaches to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Future medical prospects for Sandostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

The soluble interleukin-2 receptor: biology, function, and clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Ras oncoprotein induces CD44 cleavage through phosphoinositide 3-OH kinase and the rho family of small G proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Myoepithelial-specific CD44 shedding contributes to the anti-invasive and antiangiogenic phenotype of myoepithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Myoepithelial-specific CD44 shedding is mediated by a putative chymotrypsin-like sheddase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Characterization of a high-affinity monoclonal antibody specific for CD44v6 as candidate for immunotherapy of squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Development of a bispecific F(ab')2 conjugate against the complement receptor CR3 of macrophages and a variant CD44 antigen of rat pancreatic adenocarcinoma for redirecting macrophage-mediated tumor cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Specific cytotoxic T lymphocytes in gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Growth retardation of tumors by adoptive transfer of cytotoxic T lymphocytes reprogrammed by CD44v6-specific scFv:zeta-chimera

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Efficient lysis of CD44v7/8-presenting target cells by genetically engineered cytotoxic T-lymphocytes--a model for immunogene therapy of cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Regulation of ?V?3 and ?V?5 integrins by dexamethasone in normal human osteoblastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Depletion of alphaV integrins from osteosarcoma cells by intracellular antibody expression induces bone differentiation marker genes and suppresses gelatinase (MMP-2) synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

In vivo therapy of malignant melanoma by means of antagonists of alphav integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Inhibition of vascular smooth muscle cell adhesion and migration by c7E3 Fab (abciximab): a possible mechanism for influencing restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Molecular cloning and functional expression of contortrostatin, a homodimeric disintegrin from southern copperhead snake venom

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Peptidomimetic antagonists of alphavbeta3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Engagement of the osteoclast integrin alpha v beta 3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

Osteopontin stimulates gelsolin-associated phosphoinositide levels and phosphatidylinositol triphosphate-hydroxyl kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900037-3

7 January 2021

10.1016/S0304-419X(01)00037-3

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11825687